6 CHAPTER 6 134 Reference 1. Lund N, Barloese M, Petersen A, Haddock B, Jensen R. Chronobiology differs between men and women with cluster headache, clinical phenotype does not. Neurology. 2017;88(11):1069-1076. 2. Lund N, Petersen A, Snoer A, Jensen RH, Barloese M. Cluster headache is associated with unhealthy lifestyle and lifestyle-related comorbid diseases: Results from the Danish Cluster Headache Survey. Cephalalgia. 2019;39(2):254-263. 3. Brandt RB, Doesborg PGG, Haan J, Ferrari MD, Fronczek R. Pharmacotherapy for Cluster Headache. CNS Drugs. 2020;34(2):171-184. 4. Vollesen AL, Benemei S, Cortese F, et al. Migraine and cluster headache - the common link. J Headache Pain. 2018;19(1):89. 5. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38(1):1-211. 6. May A, Schwedt TJ, Magis D, et al. Cluster headache. Nat Rev Dis Primers. 2018;4:18006. 7. Sjaastad O, Shen JM, Stovner LJ, Elsas T. Cluster headache in identical twins. Headache. 1993;33(4):214-217. 8. Rainero I, Gallone S, Valfrè W, et al. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology. 2004;63(7):1286-1288. 9. Fourier C, Ran C, Steinberg A, et al. Analysis of HCRTR2 Gene Variants and Cluster Headache in Sweden. Headache. 2019;59(3):410-417. 10. Schürks M, Kurth T, Geissler I, et al. Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology. 2006;66(12):1917-1919. 11. Weller CM, Wilbrink LA, HouwingDuistermaat JJ, et al. Cluster headache and the hypocretin receptor 2 reconsidered: a genetic association study and meta-analysis. Cephalalgia. 2015;35(9):741-747. 12. Gibson KF, Santos AD, Lund N, Jensen R, Stylianou IM. Genetics of cluster headache. Cephalalgia. 2019;39(10):1298-1312. 13. Bacchelli E, Cainazzo MM, Cameli C, et al. A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants. J Headache Pain. 2016;17(1):114. 14. Ran C, Fourier C, Michalska JM, et al. Screening of genetic variants in ADCYAP1R1, MME and 14q21 in a Swedish cluster headache cohort. J Headache Pain. 2017;18(1):88. 15. Wilbrink LA, Weller CM, Cheung C, et al. Stepwise web-based questionnaires for diagnosing cluster headache: LUCA and QATCH. Cephalalgia. 2013;33(11):924-931. 16. de Mutsert R, den Heijer M, Rabelink TJ, et al. The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection. Eur J Epidemiol. 2013;28(6):513-523. 17. Guo Y, He J, Zhao S, et al. Illumina human exome genotyping array clustering and quality control. Nat Protoc. 2014;9(11):2643-2662. 18. Grove ML, Yu B, Cochran BJ, et al. Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS One. 2013;8(7):e68095. 19. Anderson CA, Pettersson FH, Clarke GM, et al. Data quality control in genetic case-control association studies. Nat Protoc. 2010;5(9):15641573. 20. Loh PR, Danecek P, Palamara PF, et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat Genet. 2016;48(11):1443-1448. 21. Farh KK, Marson A, Zhu J, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518(7539):337-343. 22. Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8(1):1826. 23. Pruim RJ, Welch RP, Sanna S, et al. LocusZoom: regional visualization of genomewide association scan results. Bioinformatics. 2010;26(18):2336-2337.
RkJQdWJsaXNoZXIy MTk4NDMw